Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	TGF-beta signaling pathway	5/94	4.613881700165173e-08	2.076246765074328e-06	89.65168539325843	-243.34942399375765	FBN1;SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Pancreatic cancer	4/76	1.4558243895816926e-06	2.1837365843725388e-05	74.03703703703704	-172.05130589538587	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Chronic myeloid leukemia	4/76	1.4558243895816926e-06	2.1837365843725388e-05	74.03703703703704	-172.05130589538587	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Colorectal cancer	4/86	2.39527906270035e-06	2.6946889455378937e-05	64.92682926829268	-155.35089438097907	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	4/100	4.3860489555289296e-06	3.9474440599760366e-05	55.361111111111114	-136.84140632930726	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Th17 cell differentiation	4/107	5.748185919763435e-06	4.311139439822576e-05	51.55339805825243	-129.15697540979687	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Relaxin signaling pathway	4/129	1.2102075208036114e-05	7.236042657182764e-05	42.36266666666667	-109.74601143561226	ACTA2;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	FoxO signaling pathway	4/131	1.286407583499158e-05	7.236042657182764e-05	41.68503937007874	-108.26148696115065	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Gastric cancer	4/149	2.14182517183331e-05	0.0001070912585916655	36.42758620689655	-96.46283757609443	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Hepatitis B	4/162	2.979383554686203e-05	0.00011446868147689564	33.37552742616034	-89.36652156273904	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Hippo signaling pathway	4/163	3.052498172717217e-05	0.00011446868147689564	33.16142557651992	-88.86135909767627	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Cellular senescence	4/156	2.5674697719867903e-05	0.00011446868147689564	34.719298245614034	-92.51470316480022	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Hepatocellular carcinoma	4/168	3.4380880466544094e-05	0.0001190107400764988	32.13008130081301	-86.4138745753221	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Diabetic cardiomyopathy	4/203	7.221114673256542e-05	0.00022413793593779277	26.36180904522613	-72.26295411298177	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Adherens junction	3/71	7.471264531259759e-05	0.00022413793593779277	50.42016806722689	-93.79891173136292	SMAD3;TGFBR1;TGFBR2
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	4/219	9.708345438267137e-05	0.0002730472154512632	24.350387596899225	-67.12577033726024	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Chagas disease	3/102	0.00021994493140062025	0.000582207171354583	34.497835497835496	-68.58379435140506	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Osteoclast differentiation	3/127	0.0004201187826005964	0.001050296956501491	27.456221198156683	-56.21805005538481	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Apelin signaling pathway	3/137	0.0005248515914701949	0.0012430695587451984	25.375266524520256	-52.38188378130509	ACTA2;SMAD3;TGFBR1
KEGG_2021_Human	Glycosaminoglycan biosynthesis	2/53	0.0018378173017361363	0.004135088928906307	39.299019607843135	-47.75438384041307	CHST14;DSE
KEGG_2021_Human	Inflammatory bowel disease	2/65	0.002752148243719554	0.005762757827267866	31.765873015873016	-40.07734547796954	SMAD3;TGFB1
KEGG_2021_Human	Pathways in cancer	4/531	0.0028173482711087343	0.005762757827267866	9.539531941808981	-25.060320343159585	SMAD3;TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Endocytosis	3/252	0.0030593909359302026	0.005985764874646049	13.457831325301205	-28.324076005028484	SMAD3;TGFBR1;TGFBR2
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.008602125218372614	11.412915851272016	-23.74866982495136	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	MAPK signaling pathway	3/294	0.0047334851717591615	0.008602125218372614	11.45360824742268	-23.841254126382374	TGFB1;TGFBR1;TGFBR2
KEGG_2021_Human	Cell cycle	2/124	0.009704304916610982	0.016795912355672855	16.2827868852459	-22.027132854342252	SMAD3;TGFB1
KEGG_2021_Human	Vascular smooth muscle contraction	2/133	0.011103972768351109	0.01850662128058518	15.146946564885496	-20.537590301958808	ACTA2;MYH11
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.09303443980423584	18.962174940898347	-11.032973182262484	TGFB1
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.09346540532408813	18.183673469387756	-10.63265628196324	TGFB1
KEGG_2021_Human	Renal cell carcinoma	1/69	0.08225170002715665	0.12337755004073497	13.071895424836601	-7.854937277937848	TGFB1
KEGG_2021_Human	Leishmaniasis	1/77	0.09138288226635771	0.13265257103180958	11.68421052631579	-7.04872976578505	TGFB1
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.1491282818211962	9.961298377028713	-6.010407578745034	TGFB1
KEGG_2021_Human	Rheumatoid arthritis	1/93	0.1094003568916107	0.14918230485219644	9.632850241545894	-5.8073541800756905	TGFB1
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.14921815868790894	9.32514619883041	-5.615549699272252	TGFB1
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.15350563044361962	8.764576457645765	-5.262086311101535	TGFB1
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.16297256921707295	7.964964964964965	-4.748494648054986	TGFB1
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	1/143	0.163651680714637	0.19903582789618016	6.2018779342723	-3.57415842622014	SMAD3
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.20868279241152307	5.70995670995671	-3.235678410841787	TGFB1
KEGG_2021_Human	Tight junction	1/169	0.19067020323006928	0.21450397863382795	5.224867724867725	-2.8972129419331236	MYH11
KEGG_2021_Human	Wnt signaling pathway	1/166	0.1875932968535885	0.21450397863382795	5.321885521885521	-2.9652743858654524	SMAD3
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.2215565882217289	4.896958410924891	-2.6658400097237527	TGFB1
KEGG_2021_Human	Pathogenic Escherichia coli infection	1/197	0.21888628489075546	0.22906704232753478	4.462585034013605	-2.3563138595912863	MYH11
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.22906704232753478	4.5823152995927865	-2.441961042053517	TGFBR2
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.2319379110310735	4.283224400871459	-2.2275706216550177	TGFB1
KEGG_2021_Human	Regulation of actin cytoskeleton	1/218	0.2394639268571876	0.2394639268571876	4.019969278033794	-2.037730229066884	MYH11
